PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

This phase III randomized trial evaluates PD-1 inhibitor plus chemotherapy followed by immediate versus salvage locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma. The study aims to evaluate whether salvage locoregional radiotherapy is non-inferior to immediate radiotherapy following PD-1 inhibitor plus GP in de novo metastatic NPC, with potential for reduced toxicity.

NCT Number	NCT07235319
Lead Sponsor	Sun Yat-sen University
Conditions	Nasopharangeal Cancer, Distant Metastasis
Enrollment	260 participants
Start Date	2025-11-20
Primary Completion	2031-11-20 (estimated)
Study Completion	2034-11-20 (estimated)
Updated on ClinicalTrials.gov	2025-11-19